PTCT icon

PTC Therapeutics

68.69 USD
-2.16
3.05%
At close Updated Apr 10, 4:00 PM EDT
Pre-market
After hours
68.69
0.00
0%
1 day
-3.05%
5 days
1.36%
1 month
0.19%
3 months
-11.47%
6 months
3.71%
Year to date
-10.49%
1 year
70.49%
5 years
45.75%
10 years
1,004.34%
 

About: PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Employees: 991

0
Funds holding %
of 8,115 funds
0
Analysts bullish %
of 5 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™